Introduction: Endocervical glandular atypia is relatively rarely diagnosed by Pap smears. A significant proportion of follow-up histological samples show no premalignant or malignant lesions. The observed cytomorphological findings in premalignant glandular lesions overlap with histologically proven reactive lesions. Methods: A total of 45 conventional Pap smears diagnosed as atypical endocervical cells, not otherwise specified (AEC, NOS) with human papillomavirus (HPV) status available were blindly evaluated in a search for 38 cytomorphological features representing background, architectural, cellular, and nuclear features. Of the cases, 30 represented histologically proven benign changes, and 15 represented histologically proven adenocarcinoma in situ (AIS) or endocervical adenocarcinoma (EAC) cases. The benign biopsies were re-evaluated, and the associations of the cytomorphological features or combinations of them with specific histological features and entities were statistically examined. Results: The most frequent histological findings in the benign group were squamous metaplasia, inflammation, tubal metaplasia, and microglandular hyperplasia. The statistical analysis revealed cytological features associated with squamous metaplastic changes, inflammation, and microglandular hyperplasia. Unfortunately, no cytomorphological feature was sufficiently specific to confidently leave the lesion without follow-up and histological correlation. Degeneration and nuclear crowding were the most salient features that distinguished the instances of glandular atypia with benign follow-up histology from those with histologically proven AIS or EAC (26.7 vs. 60.0%, p = 0.030, and 50.0 vs. 86.7%, p = 0.017). Conclusion: Additional methods besides cytomorphology are required to reliably distinguish smears with AEC, NOS harbouring only benign histological changes from those exhibiting endocervical glandular malignancy.

The incidence of endocervical glandular atypia has previously been reported to vary from 0.1% to 2.1% [1‒11] with an average of 0.29%, according to a significant meta-analysis of 24 studies [12]. Cytological diagnoses of atypical glandular cells, not otherwise specified (AGC, NOS); atypical glandular cells, favour neoplastic (AGC, FN); and adenocarcinoma in situ (AIS) have been shown to have a progressively better association with neoplasia and, notably, specifically to cervical glandular malignancies [1, 5, 6, 11, 13]. However, in Pap smears showing only mild glandular atypia without any squamous atypia, the follow-up histology is benign in 38–79% of the cases [2, 3, 5, 10, 13]. Where benign histology has been specified, cervicitis with or without squamous metaplasia, tubal metaplasia, microglandular hyperplasia, and endocervical or endometrial polyps have been among the most frequently encountered findings, whether alone or in combination [2, 3, 5, 10]. Reserve cell hyperplasia, endometriosis, leiomyomas, IUD effects, radiation changes, decidual reaction of the cervix, chronic endometritis, and cases with no diagnostic histological changes have also been reported [2, 3, 5‒10].

The cytomorphological features predicting AIS and endocervical adenocarcinoma (EAC) have previously been studied and described [7, 14‒17]. The features associated with benign endocervical changes have been less well documented, although reactive and reparative cellular changes have been recognized as a significant source of false-positive Pap smears [1, 18]. Moreover, the cytological features of the benign changes described are somewhat inconsistent and overlapping even with the cytological changes encountered in AIS [19‒23]. The aim of this study was to identify single or combined cytomorphological features that could predict specific benign endocervical changes and help distinguish them from AIS and EAC, thereby preventing overdiagnoses and consequent overtreatment.

A laboratory information system search for cytological diagnosis of AEC, NOS was performed to find 30 cases with cytological endocervical cell atypia and without any squamous atypia. Only cases with a negative follow-up biopsy, including an adequately sampled transformation zone and a negative follow-up history up to the search date, were included in the study. In addition, 15 cases with AEC, NOS only in cytology with AIS or EAC in the follow-up biopsy were selected as the control group. Only cases with an available high-risk human papillomavirus (hrHPV) test result were included.

All 45 cytological samples were taken between 2013 and 2019. The samples were originally analysed in Fimlab Laboratories Oy, which serves the Tampere University Hospital and regional hospitals in Finland’s Pirkanmaa region. The samples consisted of conventional Pap smears and were reported according to the Bethesda Classification for Reporting Cervical Cytology 2014 [23‒25].

The Abbot RealTime hrHPV PCR assay (RealTime; Abbot, Wiesbaden, Germany) was used to detect the hrHPV DNA. The test recognizes 14 hrHPV genotypes, including types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68. The hrHPV genotypes 16 and 18 were reported separately, and the rest of the genotypes were reported as “other hrHPV than 16 or 18” [26].

The 45 Pap smears were initially diagnosed as glandular atypia by general pathologists in routine practice and, in the present study, were blindly reviewed by two cytopathologists with 25 and 10 years of respective experience in cytopathology. The Pap smears were analysed to search for 38 different cytological features described earlier [17] and consisting of background, cellular, nuclear, and architectural features (Table 1). The findings reported in the study are based on the consensus of the two cytopathologists.

Table 1.

38 cytomorphological features analysed in AEC, NOSa Pap smears, and their distribution among histologically proven AIS/EACb and benign cases

Pap smears with histological AIS/EACb, n (%)Pap smears with benign follow-up, n (%)
Background features 
 Clean 4/15 (26.7) 5/30 (16.7) 
 Bloody 7/15 (46.7) 21/30 (70.0) 
 Inflammatory 8/15 (53.3) 9/30 (30.0) 
 Inflammatory debris 1/15 (6.7) 1/30 (3.3) 
 Necrotic 0/15 (0.0) 0/30 (0.0) 
 Apoptotic debris 0/15 (0.0) 0/30 (0.0) 
Architectural features 
 Scant cellularity 0/15 (0.0) 1/30 (3.3) 
 High cellularity 3/15 (20.0) 8/30 (26.7) 
 Single atypical cells 0/15 (0.0) 0/30 (0.0) 
 Loss of polarity 0/15 (0.0) 1/30 (3.3) 
 Loss of honeycomb pattern 3/15 (20.0) 9/30 (30.0) 
 Pseudostratified strips 2/15 (13.3) 1/30 (3.3) 
 Palisading borders 4/15 (26.6) 5/30 (16.7) 
 Rosettes 0/15 (0.0) 0/30 (0.0) 
 Feathering 2/15 (13.3) 4/30 (13.3) 
 Papillary groups 2/15 (13.3) 3/30 (10.0) 
Cellular features 
 Columnar cell shape 15/15 (100) 30/30 (100) 
 Cuboidal cell shape 0/15 (0.0) 0/30 (0.0) 
 Irregular cell borders 0/15 (0.0) 0/30 (0.0) 
 Increased nuclear/cytoplasmic ratio 2/15 (13.3) 2/30 (6.7) 
 Degeneration 9/15 (60.0) 8/30 (26.7) 
 Regeneration 1/15 (6.7) 5/30 (16.7) 
 Atrophy 1/15 (6.7) 0/30 (0.0) 
Nuclear features 
 Enlarged nuclei 6/15 (40.0) 7/30 (23.3) 
 Nuclear hyperchromasia 3/15 (20.0) 2/30 (6.7) 
 Nuclear membrane irregularity 0/15 (0.0) 0/30 (0.0) 
 Nuclear crowding 13/15 (86.7) 15/30 (50.0) 
 Oval nuclei 0/15 (0.0) 0/30 (0.0) 
 Elongated nuclei 1/15 (6.7) 8/30 (26.7) 
 Nuclear pleomorphism 0/15 (0.0) 0/30 (0.0) 
 Nucleoli 0/15 (0.0) 0/30 (0.0) 
 Macronucleoli 0/15 (0.0) 0/30 (0.0) 
 Finely granular chromatin 0/15 (0.0) 3/30 (10.0) 
 Coarsely granular chromatin 0/15 (0.0) 0/30 (0.0) 
 Chromatin clearing 3/15 (20.0) 1/30 (3.3) 
 Nuclear vacuoles 0/15 (0.0) 1/30 (3.3) 
 Mitotic figures 0/15 (0.0) 0/30 (0.0) 
 Apoptotic bodies 0/15 (0.0) 0/30 (0.0) 
Pap smears with histological AIS/EACb, n (%)Pap smears with benign follow-up, n (%)
Background features 
 Clean 4/15 (26.7) 5/30 (16.7) 
 Bloody 7/15 (46.7) 21/30 (70.0) 
 Inflammatory 8/15 (53.3) 9/30 (30.0) 
 Inflammatory debris 1/15 (6.7) 1/30 (3.3) 
 Necrotic 0/15 (0.0) 0/30 (0.0) 
 Apoptotic debris 0/15 (0.0) 0/30 (0.0) 
Architectural features 
 Scant cellularity 0/15 (0.0) 1/30 (3.3) 
 High cellularity 3/15 (20.0) 8/30 (26.7) 
 Single atypical cells 0/15 (0.0) 0/30 (0.0) 
 Loss of polarity 0/15 (0.0) 1/30 (3.3) 
 Loss of honeycomb pattern 3/15 (20.0) 9/30 (30.0) 
 Pseudostratified strips 2/15 (13.3) 1/30 (3.3) 
 Palisading borders 4/15 (26.6) 5/30 (16.7) 
 Rosettes 0/15 (0.0) 0/30 (0.0) 
 Feathering 2/15 (13.3) 4/30 (13.3) 
 Papillary groups 2/15 (13.3) 3/30 (10.0) 
Cellular features 
 Columnar cell shape 15/15 (100) 30/30 (100) 
 Cuboidal cell shape 0/15 (0.0) 0/30 (0.0) 
 Irregular cell borders 0/15 (0.0) 0/30 (0.0) 
 Increased nuclear/cytoplasmic ratio 2/15 (13.3) 2/30 (6.7) 
 Degeneration 9/15 (60.0) 8/30 (26.7) 
 Regeneration 1/15 (6.7) 5/30 (16.7) 
 Atrophy 1/15 (6.7) 0/30 (0.0) 
Nuclear features 
 Enlarged nuclei 6/15 (40.0) 7/30 (23.3) 
 Nuclear hyperchromasia 3/15 (20.0) 2/30 (6.7) 
 Nuclear membrane irregularity 0/15 (0.0) 0/30 (0.0) 
 Nuclear crowding 13/15 (86.7) 15/30 (50.0) 
 Oval nuclei 0/15 (0.0) 0/30 (0.0) 
 Elongated nuclei 1/15 (6.7) 8/30 (26.7) 
 Nuclear pleomorphism 0/15 (0.0) 0/30 (0.0) 
 Nucleoli 0/15 (0.0) 0/30 (0.0) 
 Macronucleoli 0/15 (0.0) 0/30 (0.0) 
 Finely granular chromatin 0/15 (0.0) 3/30 (10.0) 
 Coarsely granular chromatin 0/15 (0.0) 0/30 (0.0) 
 Chromatin clearing 3/15 (20.0) 1/30 (3.3) 
 Nuclear vacuoles 0/15 (0.0) 1/30 (3.3) 
 Mitotic figures 0/15 (0.0) 0/30 (0.0) 
 Apoptotic bodies 0/15 (0.0) 0/30 (0.0) 

aAtypical endocervical cells, NOS.

bAdenocarcinoma in situ/endocervical adenocarcinoma.

Of the above features, the cellularity was considered scant when the smear was satisfactory according to the Bethesda 2014 criteria, but the amount of endocervical cells was just above the threshold [23‒25]. By contrast, when the number of endocervical cells was plentiful, the cellularity was regarded as high. Degeneration was defined as the loss of well-preserved cell borders with or without partial or complete loss of cytoplasm accompanied by some nuclear swelling. Nuclei were considered enlarged when the size of an endocervical cell nucleus was >2 times the size of a normal endocervical cell nucleus. Nuclear pleomorphism was defined as the >3 times variation of nuclear size and shape irregularity. All cytomorphological features were agreed upon by two observers based on the same slides. The originally benign diagnosed biopsies were revised and analysed in a search for the following histological features: inflammation (subcategorized as chronic, mixed, acute, and follicular), ulceration, granulation tissue, squamous metaplasia, immature squamous metaplasia, atypical squamous metaplasia, microglandular hyperplasia, reserve cell hyperplasia, tubal metaplasia, eosinophilic change, and polyps. The number of inflammatory cells was quantitively evaluated in haematoxylin and eosin slides and graded 0 in case of no inflammatory cells; 1+ in the case of only scattered inflammatory cells or small inflammatory cell groups of <10 cells; 2+ in the case of more diffuse inflammatory cell infiltrates with inflammatory cell groups of >10 cells; and 3+ in the case of dense, diffuse and sheet-like inflammatory cell infiltrates. Categories 2+ and 3+ were considered significant. For the other cytomorphological features, the evaluation was based on the Bethesda 2014 criteria and cytology textbooks [23, 25, 27]. All statistical analyses were performed with SPSS version 28 (IBM SPSS Statistics for Windows, Version 28.0. Armonk, NY: IBM Corp.). Univariate associations were examined using χ2 or Fisher’s exact tests. Further analyses of the cytomorphological features were performed to define the combination of features associated with the occurrence of benign histology with a forward stepwise multivariable logistic regression analysis using probability values of <0.05 for the entry of features.

The study was approved by the Ethical Committee of Pirkanmaa Health Care District (R16022). It was not deemed necessary to seek the individuals’ informed consent. The study was conducted in accordance with the Declaration of Helsinki.

The patients in the AIS/EAC group had an average age of 39.0 (SD ± 6.3) years, while those in the benign group had an average age of 43.9 (SD ± 10.2) years. All Pap smears with a negative follow-up history had been taken prior to 2018, resulting in a follow-up time of five or more years, with the exception of one smear taken in 2018, which had a follow-up period of 4 years. Twenty of the 30 patients (66.7%) had a negative hrHPV test result at the time of the cytological diagnosis of AEC, NOS. One patient (3.3%) tested positive for HPV16, 2/30 (6.7%) tested positive for HPV18 and 7/30 patients (23.3%) presented with hrHPV genotypes other than 16 or 18. All hrHPV-positive patients at the baseline, who showed no evidence of malignancies during the follow-up, showed negative hrHPV test results later during the follow-up period.

The most frequent histological finding among this benign group was squamous metaplasia (22/30, 73.3%), followed by significant inflammation (16/30, 53.3%), tubal metaplasia (10/30, 33.3%), and microglandular hyperplasia (6/30, 20.0%) (Table 2). The significant inflammation was mixed in every biopsy and was frequently accompanied by squamous metaplastic changes and ulceration (Table 2). Polyps were not encountered in any of the histological samples, and only scattered cases showed reserve cell hyperplasia (1/30, 3.3%), eosinophilic change (1/30, 3.3%), granulation tissue (2/30, 6.7%), and follicular inflammation (1/30, 3.3%).

Table 2.

Most frequent histological findings among AEC, NOSa Pap smears with a benign follow-up history

Cases, nPercentage
Squamous metaplasia 22 73.3 
 Squamous metaplasia, NOS 16.7 
 Squamous metaplasia, immature 15 50.0 
 Squamous metaplasia, atypical 16.7 
 Squamous metaplasia, immature + atypical 10 
Significant inflammation 16 53.3 
 With mixed inflammatory infiltrate 16 53.3 
 With ulceration 26.7 
 With squamous metaplasia 10 33.3 
  With squamous metaplasia, NOS 10.0 
  With squamous metaplasia, immature 16.7 
  With squamous metaplasia, atypical 10.0 
  With squamous metaplasia, immature+ atypical 3.3 
Tubal metaplasia 10 33.3 
Microglandular hyperplasia 20.0 
Cases, nPercentage
Squamous metaplasia 22 73.3 
 Squamous metaplasia, NOS 16.7 
 Squamous metaplasia, immature 15 50.0 
 Squamous metaplasia, atypical 16.7 
 Squamous metaplasia, immature + atypical 10 
Significant inflammation 16 53.3 
 With mixed inflammatory infiltrate 16 53.3 
 With ulceration 26.7 
 With squamous metaplasia 10 33.3 
  With squamous metaplasia, NOS 10.0 
  With squamous metaplasia, immature 16.7 
  With squamous metaplasia, atypical 10.0 
  With squamous metaplasia, immature+ atypical 3.3 
Tubal metaplasia 10 33.3 
Microglandular hyperplasia 20.0 

aAtypical endocervical cells, NOS.

The AEC, NOS Pap smears with AIS or EAC in the follow-up biopsy were taken between 2013 and 2019. Each patient in this group was hrHPV-positive. Six of these 15 patients (40.0%) presented with HPV18 infection, 5/15 (33.3%) with HPV16 infection, and 4/15 (26.7%) had infection with hrHPV genotypes other than HPV16 or HPV18. The final diagnoses after the loop electrosurgical excision procedure or hysterectomy in this group were 1/15 (6.7%) EAC, 1/15 (6.7%) EAC + high-grade squamous intraepithelial lesion (HSIL), 10/15 (66.7%) AIS, and 3/15 (20.0%) AIS + HSIL.

In the analysis of cytological features of the Pap smears with benign follow-up histology, the inflammatory background revealed by the smears was correlated with significant inflammation in histology (15/31 [48.4%] versus 2/14 [14.3%], p = 0.029) (shown in Fig. 1). No inflammatory background was encountered in the smears presenting with chronic inflammation only in histology, but inflammatory background was instead more common in smears with mixed inflammatory infiltrates in corresponding histological samples (0/8 [0%] versus 17/37 [45.9%], p = 0.017). Nuclear crowding was more frequent in smears without significant inflammation in histology (22/29 [75.8%] versus 6/16 [37.5%], p = 0.01). Moreover, the nuclei of the glandular cells were more frequently considered to be elongated in smears without significant histological inflammation in the follow-up biopsies (6/14 [42.9%] versus 3/31 [9.7%], p = 0.017). Elongated nuclei were also seen more frequently in smears with histological microglandular hyperplasia (4/6 [66.7%] versus 5/39 [12.8%], p = 0.010).

Fig. 1.

a A mixed inflammatory infiltrate consisting of neutrophilic granulocytes, a few plasma cells, and scattered lymphocytes can be seen in the background of a Pap smear (Papanicolaou stain, original magnification, ×400). b There is a superficial mixed inflammation consisting mainly of plasma cells and neutrophilic granulocytes in benign endocervical mucosa showing reactive changes. Inflammatory background in Pap smears correlated with significant mixed inflammation in histology (haematoxylin-eosin, original magnification, ×200).

Fig. 1.

a A mixed inflammatory infiltrate consisting of neutrophilic granulocytes, a few plasma cells, and scattered lymphocytes can be seen in the background of a Pap smear (Papanicolaou stain, original magnification, ×400). b There is a superficial mixed inflammation consisting mainly of plasma cells and neutrophilic granulocytes in benign endocervical mucosa showing reactive changes. Inflammatory background in Pap smears correlated with significant mixed inflammation in histology (haematoxylin-eosin, original magnification, ×200).

Close modal

Degeneration was registered more often in smears without squamous metaplasia or immature squamous metaplasia than in those with squamous metaplastic changes (13/24 [54.2%] versus 4/21 [19.0%], p = 0.015, and 15/30 [50.0%] versus 2/15 [13.3%], p = 0.017). Chromatin pattern was finely granular in 3/15 (20.0%) of the smears with immature squamous metaplasia in their histology compared to 0/30 (0%) in other histotypes (p = 0.032) (shown in Fig. 2). Cytological scant cellularity was associated with granulation tissue formation in histology (1/2 [50.0%] versus 0/43 [0%], p = 0.044), and palisading cell borders were also encountered more often in smears with granulation tissue in histology (2/2 [100%] versus 7/43 [16.3%], p = 0.036) (shown in Fig. 3).

Fig. 2.

a Mildly enlarged endocervical cell nuclei with finely granular chromatin in a crowded fragment (Papanicolaou stain, original magnification, ×400). b An example of immature squamous metaplasia with a layer of preserved cytologically benign endocervical cells on top of the squamous metaplastic cells. Endocervical glandular cells with finely granular chromatin pattern were most frequently encountered in association with immature squamous metaplasia in histology (haematoxylin-eosin, original magnification, ×400).

Fig. 2.

a Mildly enlarged endocervical cell nuclei with finely granular chromatin in a crowded fragment (Papanicolaou stain, original magnification, ×400). b An example of immature squamous metaplasia with a layer of preserved cytologically benign endocervical cells on top of the squamous metaplastic cells. Endocervical glandular cells with finely granular chromatin pattern were most frequently encountered in association with immature squamous metaplasia in histology (haematoxylin-eosin, original magnification, ×400).

Close modal
Fig. 3.

a There is a thick epithelial fragment with palisading borders in a background of scattered inflammatory cells consisting mainly of neutrophilic granulocytes (Papanicolaou stain, original magnification, ×400). b Figure represents granulation tissue with oedemic stroma, reactive vascular and stromal cell proliferation, and neutrophil-dominant background inflammation. Palisading cell borders, as well as overall scant cellularity in Pap smears were associated with granulation tissue formation in histology (haematoxylin-eosin, original magnification, ×100).

Fig. 3.

a There is a thick epithelial fragment with palisading borders in a background of scattered inflammatory cells consisting mainly of neutrophilic granulocytes (Papanicolaou stain, original magnification, ×400). b Figure represents granulation tissue with oedemic stroma, reactive vascular and stromal cell proliferation, and neutrophil-dominant background inflammation. Palisading cell borders, as well as overall scant cellularity in Pap smears were associated with granulation tissue formation in histology (haematoxylin-eosin, original magnification, ×100).

Close modal

Degeneration and nuclear crowding were the cytological features that best distinguished the glandular atypia with benign follow-up histology from those with histologically proven AIS or EAC (shown in Fig. 4). Degeneration was observed in only 8/30 (26.7%) of the smears in the benign group and in 9/15 (60.0%) of the smears in the carcinoma group (p = 0.030) and nuclear crowding in 15/30 (50.0%) and 13/15 (86.7%) of the smears (p = 0.017), respectively. The other way around, degeneration and nuclear crowding were more common in malignant-proven Pap smears.

Fig. 4.

a, b Examples of atypical endocervical cell fragments with degenerative changes, nuclear crowding, and variation of size and shape of the nuclei (Papanicolaou stain, original magnification, ×400). Degeneration and nuclear crowding were the best cytological features distinguishing the AEC, NOS Pap smears harbouring a malignant endocervical glandular lesion from those with histologically proven benign changes only.

Fig. 4.

a, b Examples of atypical endocervical cell fragments with degenerative changes, nuclear crowding, and variation of size and shape of the nuclei (Papanicolaou stain, original magnification, ×400). Degeneration and nuclear crowding were the best cytological features distinguishing the AEC, NOS Pap smears harbouring a malignant endocervical glandular lesion from those with histologically proven benign changes only.

Close modal

Most of the 38 features investigated in the cytomorphological analysis showed no association with specific benign pathologies but presented with similar frequencies in the benign and neoplastic-proven Pap smears (Table 1). Many cytomorphological features, including necrosis, apoptotic debris, cuboidal cell shape, irregular cell borders, nuclear membrane irregularities, oval nuclei, nuclear pleomorphism, nucleoli, macronucleoli, coarsely granular chromatin, single atypical cells, mitotic figures, apoptotic bodies and rosettes, were not encountered in any of the smears. In the statistical analysis, no combinations of cytomorphological features associated with the benign pathologies were encountered.

The most common benign histological changes observed in AEC, NOS Pap smears in the present study were squamous metaplasia, inflammation, or a combination of these, which is in line with several earlier studies [3, 5, 10, 11, 28‒30]. Given that inflammation can induce reactive atypia and, as a protective response, metaplastic squamous changes, it is unsurprising to see them occur in the same specimen [3, 10, 11, 29]. The cause of endocervical cell atypia interpreted as reactive or reparative remains undefined in many previous studies [1, 3, 31, 32]. Reactive or reparative changes in cytology are known to be caused by various benign and even malignant conditions, including infection and inflammation [33‒35]. Therefore, we discuss them in association with inflammatory changes.

In our study, inflammatory background in AEC, NOS Pap smears was associated with significant mixed inflammation in the benign follow-up biopsies. The most significant published cytomorphological features associated with reactive or reparative endocervical cell atypia are listed in Table 3. In summary, nuclear size in reactive/reparative endocervical cell atypia can vary from normal or uniformly enlarged to prominent changes in size and shape. Reactive/reparative endocervical cell atypia may be associated with nuclear membrane irregularities and sometimes even with nuclear hyperchromasia (Table 3). Nuclear/cytoplasmic ratio has been described as ranging from normal to high, and the nucleoli in reactive/reparative endocervical cells may also vary with respect to size (Table 3). Crowding or nuclear overlapping often occur, and mitotic figures may also be encountered occasionally. In most cases, the nucleolar chromatin pattern has been described as even or fine, and the architectural features associated with AIS and EAC, including feathering, rosettes, and palisades, have been absent. In other words, the fine and even chromatin pattern in atypical endocervical cells and the lack of architectural abnormalities seem to be the most constant features differentiating reactive/reparative atypia from the neoplastic endocervical lesions (Table 3). In the case of inflammation-induced reactive cellular changes, the presence of the pleomorphic inflammatory cells and identification of tingible-body macrophages have been suggested to support the benign interpretation of the endocervical cell atypia seen in this group of samples [36].

Table 3.

Summary of reported cytomorphological features of reactive/reparative endocervical cell atypia

ReferenceStudy typeStudy seriesnFinal histological diagnosisScope of the studyMain cytomorphological findings
Lee [1] (1995) Original article Pap smears with glandular atypia, probably reactive (with or without SILa40 14 HSILb Reactive cells Crowded groups 
1 LSILc Normal-sized nuclei 
24 benign Fine chromatin 
Obscuring factors: blood, degeneration 
Nasu [3] (1993) Original article Pap smears with reactive glandular atypia 241 117 SILa Reactive glandular atypia Minimal nuclear overlap 
2 SCCd 
Some hyperchromatic nuclei 
13 low-grade glandular atypia Some enlarged nuclei 
Fine chromatin 
109 benign Absent/minimal nuclear irregularity 
Nucleolar size variation 
Rare multinucleated cells 
Ghorab [31] (2000) Original article Histological specimen with reactive glandular atypia 6 endocervical reactive atypia (with or without SILaReactive glandular atypia High nuclear/cytoplasmic ratio 
Nuclear enlargement 2–3 x normal 
2–3 × variation in nuclear size 
Dark nuclei 
Fine chromatin 
Small nucleoli 
Irregular nuclear membranes 
Some nuclear overlap 
Rare multinucleated cells 
Ronnett et al. [32] (1999) Original article Pap smears with atypical glandular cells, favour reactive/NOS/favour AIS 44 3 AISe Atypical glandular cells, favour reactive Sheets or cell fragments 
Cuboidal or columnar 
cell shape 
Round or ovoid nuclei 
Atypical glandular cells, NOS Nuclear enlargement 
Nuclear hyperchromasia 
1 AISe + HSILb Nuclear overlapping 
Some macronucleoli 
Rare chromatin abnormalities 
1 EMACf 
No feathering 
No rosettes 
No palisades 
2 HSILb 
 
2 LSILc 
35 benign 
Ozkan [37] (2004) Original article Thin-layer Pap tests with glandular atypia 39 11 benign/reactive Reactive lesions Normal nuclear/cytoplasmic ratio 
9 AISe Round nuclei 
1 AISe + HSILb Fine chromatin 
1 EACg Rare nuclear size variation 
15 SILa/SCCd Minimal nuclear overlapping 
2 adenosquamous carcinomas No hyperchromasia 
No mitotic figures 
DiTomasso [38] (1996) Original article Pap smears of histologically reactive or benign lesions 29 27 benign (not further defined) Reactive lesions Low glandular cellularity 
Preserved honeycomb pattern 
Well-defined cell borders 
Round to oval nuclei 
Nuclear enlargement 
Normal nuclear/cytoplasmic ratio 
Fine chromatin 
Large nucleoli 
Absent/minimal nuclear overlapping 
Wood [36] (2007) Review article Liquid-based Pap tests with atypical glandular cells with corresponding histological follow-up Reactive endocervical cells Somewhat disordered architecture 
Slight layering of cells 
Round or oval nuclei 
Open chromatin 
Dense and dark cytoplasm with vacuoles 
Mildly increased nuclear/cytoplasmic ratio 
Spaces between the nuclei 
Torous Pitman [39] (2021) Review article Reparative changes Sheets of cells 
Bi- or multinucleation 
Cytoplasmic vacuolization and polychromasia 
Mild to pronounced nuclear enlargement 
Irregular nuclear contours 
Irregular chromatin 
Prominent and irregular nucleoli 
Occasional mitosis 
No rosettes 
No pseudostratification 
No feathering 
ReferenceStudy typeStudy seriesnFinal histological diagnosisScope of the studyMain cytomorphological findings
Lee [1] (1995) Original article Pap smears with glandular atypia, probably reactive (with or without SILa40 14 HSILb Reactive cells Crowded groups 
1 LSILc Normal-sized nuclei 
24 benign Fine chromatin 
Obscuring factors: blood, degeneration 
Nasu [3] (1993) Original article Pap smears with reactive glandular atypia 241 117 SILa Reactive glandular atypia Minimal nuclear overlap 
2 SCCd 
Some hyperchromatic nuclei 
13 low-grade glandular atypia Some enlarged nuclei 
Fine chromatin 
109 benign Absent/minimal nuclear irregularity 
Nucleolar size variation 
Rare multinucleated cells 
Ghorab [31] (2000) Original article Histological specimen with reactive glandular atypia 6 endocervical reactive atypia (with or without SILaReactive glandular atypia High nuclear/cytoplasmic ratio 
Nuclear enlargement 2–3 x normal 
2–3 × variation in nuclear size 
Dark nuclei 
Fine chromatin 
Small nucleoli 
Irregular nuclear membranes 
Some nuclear overlap 
Rare multinucleated cells 
Ronnett et al. [32] (1999) Original article Pap smears with atypical glandular cells, favour reactive/NOS/favour AIS 44 3 AISe Atypical glandular cells, favour reactive Sheets or cell fragments 
Cuboidal or columnar 
cell shape 
Round or ovoid nuclei 
Atypical glandular cells, NOS Nuclear enlargement 
Nuclear hyperchromasia 
1 AISe + HSILb Nuclear overlapping 
Some macronucleoli 
Rare chromatin abnormalities 
1 EMACf 
No feathering 
No rosettes 
No palisades 
2 HSILb 
 
2 LSILc 
35 benign 
Ozkan [37] (2004) Original article Thin-layer Pap tests with glandular atypia 39 11 benign/reactive Reactive lesions Normal nuclear/cytoplasmic ratio 
9 AISe Round nuclei 
1 AISe + HSILb Fine chromatin 
1 EACg Rare nuclear size variation 
15 SILa/SCCd Minimal nuclear overlapping 
2 adenosquamous carcinomas No hyperchromasia 
No mitotic figures 
DiTomasso [38] (1996) Original article Pap smears of histologically reactive or benign lesions 29 27 benign (not further defined) Reactive lesions Low glandular cellularity 
Preserved honeycomb pattern 
Well-defined cell borders 
Round to oval nuclei 
Nuclear enlargement 
Normal nuclear/cytoplasmic ratio 
Fine chromatin 
Large nucleoli 
Absent/minimal nuclear overlapping 
Wood [36] (2007) Review article Liquid-based Pap tests with atypical glandular cells with corresponding histological follow-up Reactive endocervical cells Somewhat disordered architecture 
Slight layering of cells 
Round or oval nuclei 
Open chromatin 
Dense and dark cytoplasm with vacuoles 
Mildly increased nuclear/cytoplasmic ratio 
Spaces between the nuclei 
Torous Pitman [39] (2021) Review article Reparative changes Sheets of cells 
Bi- or multinucleation 
Cytoplasmic vacuolization and polychromasia 
Mild to pronounced nuclear enlargement 
Irregular nuclear contours 
Irregular chromatin 
Prominent and irregular nucleoli 
Occasional mitosis 
No rosettes 
No pseudostratification 
No feathering 

aSquamous intraepithelial lesion.

bHigh-grade squamous intraepithelial lesion.

cLow-grade squamous intraepithelial lesion.

dSquamous cell carcinoma.

eAdenocarcinoma in situ.

fEndometrial adenocarcinoma.

gEndocervical adenocarcinoma.

In the present study, nuclear crowding in Pap smears was negatively correlated with significant histological inflammation. Likewise, nuclear elongation was encountered more frequently in cases without significant histological inflammation. Finely granular chromatin pattern was found to be associated with immature squamous metaplasia but not with significant histological inflammation.

Tubal metaplasia was the third most common benign histological change encountered, but in our study, it showed no association with any of the cytomorphological features investigated. In the literature, tubal metaplasia is most frequently described as strips, sheets, or groups of cells, which may show nuclear crowding with variations in nuclear size, pseudostratification, and even hyperchromatic nuclei or mitotic figures (Table 4). Typically, chromatin abnormalities are absent or mild with no apoptotic bodies or background tumour diathesis, and, when encountered, cilia and terminal bars have been considered characteristic (Table 4).

Table 4.

Summary of reported cytomorphological features of histological tubal metaplasia and microglandular hyperplasia

ReferenceStudy typeStudy seriesnFinal histological diagnosisScope of the studyMain cytomorphological findings
Babkowski [40] (1996) Original article Hysterectomy specimen without prior cervical neoplasia 25 25 benign with tubal metaplasia in 100% Diagnostically challenging endocervical cell groups Variation in nuclear size 
Abnormal chromatin patterns 
Cellular crowding 
Nuclear overlap 
Palisading 
Rosettes 
Nuclear feathering 
No cilia in most cases 
Torous and Pitman [39] (2021) Review article Tubal metaplasia Metaplastic cells singly, in pseudostratified strips, in sheets or in crowded clusters 
Columnar cell shape 
Apical terminal bars and cilia 
Oval nuclei 
Nuclear enlargement 
Slight to moderate anisonucleosis 
Mild nuclear overlap 
Mild crowding 
Occasional small nucleoli 
Rare feathering 
Rare mitosis 
No apoptotic bodies 
No tumour diathesis 
Dense, hyperchromatic groups with pseudostratification 
Cilia 
Wilbur [22] (2016) Review article Tubal metaplasia Fine chromatin 
Occasionally mitoses 
No apoptotic debris 
Wood [36] (2007) Review article Liquid-based Pap tests with atypical glandular cells with corresponding histological follow-up Tubal metaplasia Pseudostratification 
Elongated, often hyperchromatic nuclei in intercalary or peg cells 
Cilia 
Terminal bars 
No chromatin abnormalities 
Selvaggi [20] (1997) Original article Cervical smears with in situ or invasive adenocarcinoma with histological follow-up 3 tubal metaplasia Tubal metaplasia Clusters, sheets, and strips of cells 
Round to oval nuclei 
Evenly distributed fine chromatin 
Pseudoglandular formation in 2 cases 
DiTomasso [38] (1996) Original article Pap smears of histological reactive or benign lesions 29 1 tubal metaplasia Tubal metaplasia Higher nuclear/cytoplasmic ratio 
Hyperchromasia 
Fine chromatin 
Terminal bars or cilia 
Minimal nuclear overlapping 
Selvaggi [20] (1997) Original article Cervical smears with AIS or invasive adenocarcinoma with histological follow-up 3 microglandular hyperplasia Microglandular hyperplasia Clusters of small- to medium-sized cells with coarsely granular nuclear chromatin, prominent nucleoli, cytoplasmic vacuoles, with engulfment of neutrophils in 2 cases 
Clusters of large cells with ample vacuolated cytoplasm, vesicular nuclei, and prominent nucleoli in 1 case 
DiTomasso [38] (1996) Original article Pap smears of histological reactive or benign lesions 29 1 microglandular hyperplasia Microglandular hyperplasia Low glandular cellularity 
Preserved honeycomb pattern 
Well-defined cell borders 
Round to oval nuclei 
Nuclear enlargement 
Nuclear pleomorphism 
Normal nuclear/cytoplasmic ratio 
Fine chromatin 
Large nucleoli 
Absent/minimal nuclear overlapping 
Wood [36] (2007) Review article Liquid-based Pap tests with atypical glandular cells with corresponding histological follow-up Microglandular hyperplasia Three-dimensional fragments 
Small lumens 
Preservation of cell spacing 
Round nuclei 
Smooth nuclear contours 
No atypical single cells 
Clean background 
Yahr [19] (1991) Original article Pap smears of histological microglandular hyperplasia cases 25 25 microglandular hyperplasia Microglandular hyperplasia Glandular cells of varying degrees of atypia 
No specific features for microglandular hyperplasia 
Alvarez-Santín et al. [21] (1999) Original article Pap smears of histological microglandular hyperplasia cases 24 24 microglandular hyperplasia Microglandular hyperplasia Bi- or tridimensional clusters of cubic or cylindrical cells with vacuolated cytoplasm 
Basaloid-like cells 
Cells with small, round nuclei and scant cytoplasm 
Microlumina, fenestrated spaces, and preserved polarity in clusters 
Absence of nuclear peripheral dispersion in clusters 
In 80% associated inflammatory process with reactive cellular changes 
ReferenceStudy typeStudy seriesnFinal histological diagnosisScope of the studyMain cytomorphological findings
Babkowski [40] (1996) Original article Hysterectomy specimen without prior cervical neoplasia 25 25 benign with tubal metaplasia in 100% Diagnostically challenging endocervical cell groups Variation in nuclear size 
Abnormal chromatin patterns 
Cellular crowding 
Nuclear overlap 
Palisading 
Rosettes 
Nuclear feathering 
No cilia in most cases 
Torous and Pitman [39] (2021) Review article Tubal metaplasia Metaplastic cells singly, in pseudostratified strips, in sheets or in crowded clusters 
Columnar cell shape 
Apical terminal bars and cilia 
Oval nuclei 
Nuclear enlargement 
Slight to moderate anisonucleosis 
Mild nuclear overlap 
Mild crowding 
Occasional small nucleoli 
Rare feathering 
Rare mitosis 
No apoptotic bodies 
No tumour diathesis 
Dense, hyperchromatic groups with pseudostratification 
Cilia 
Wilbur [22] (2016) Review article Tubal metaplasia Fine chromatin 
Occasionally mitoses 
No apoptotic debris 
Wood [36] (2007) Review article Liquid-based Pap tests with atypical glandular cells with corresponding histological follow-up Tubal metaplasia Pseudostratification 
Elongated, often hyperchromatic nuclei in intercalary or peg cells 
Cilia 
Terminal bars 
No chromatin abnormalities 
Selvaggi [20] (1997) Original article Cervical smears with in situ or invasive adenocarcinoma with histological follow-up 3 tubal metaplasia Tubal metaplasia Clusters, sheets, and strips of cells 
Round to oval nuclei 
Evenly distributed fine chromatin 
Pseudoglandular formation in 2 cases 
DiTomasso [38] (1996) Original article Pap smears of histological reactive or benign lesions 29 1 tubal metaplasia Tubal metaplasia Higher nuclear/cytoplasmic ratio 
Hyperchromasia 
Fine chromatin 
Terminal bars or cilia 
Minimal nuclear overlapping 
Selvaggi [20] (1997) Original article Cervical smears with AIS or invasive adenocarcinoma with histological follow-up 3 microglandular hyperplasia Microglandular hyperplasia Clusters of small- to medium-sized cells with coarsely granular nuclear chromatin, prominent nucleoli, cytoplasmic vacuoles, with engulfment of neutrophils in 2 cases 
Clusters of large cells with ample vacuolated cytoplasm, vesicular nuclei, and prominent nucleoli in 1 case 
DiTomasso [38] (1996) Original article Pap smears of histological reactive or benign lesions 29 1 microglandular hyperplasia Microglandular hyperplasia Low glandular cellularity 
Preserved honeycomb pattern 
Well-defined cell borders 
Round to oval nuclei 
Nuclear enlargement 
Nuclear pleomorphism 
Normal nuclear/cytoplasmic ratio 
Fine chromatin 
Large nucleoli 
Absent/minimal nuclear overlapping 
Wood [36] (2007) Review article Liquid-based Pap tests with atypical glandular cells with corresponding histological follow-up Microglandular hyperplasia Three-dimensional fragments 
Small lumens 
Preservation of cell spacing 
Round nuclei 
Smooth nuclear contours 
No atypical single cells 
Clean background 
Yahr [19] (1991) Original article Pap smears of histological microglandular hyperplasia cases 25 25 microglandular hyperplasia Microglandular hyperplasia Glandular cells of varying degrees of atypia 
No specific features for microglandular hyperplasia 
Alvarez-Santín et al. [21] (1999) Original article Pap smears of histological microglandular hyperplasia cases 24 24 microglandular hyperplasia Microglandular hyperplasia Bi- or tridimensional clusters of cubic or cylindrical cells with vacuolated cytoplasm 
Basaloid-like cells 
Cells with small, round nuclei and scant cytoplasm 
Microlumina, fenestrated spaces, and preserved polarity in clusters 
Absence of nuclear peripheral dispersion in clusters 
In 80% associated inflammatory process with reactive cellular changes 

In our series, when the Pap smears corresponding to the histologically diagnosed tubal metaplasia cases were retrospectively reviewed, cilia were recognized in one of the ten smears (10%), which is the same frequency as that reported earlier by Ducatman et al. [41]. In our case, ciliated cells were seen in a pseudostratified strip interpreted as atypical, though the strip was not the most worrisome group of glandular cells on the slide. Babkowski et al. [40] observed ciliated cells in all smears containing diagnostically challenging endocervical cell groups but only rarely in the groups of cells causing the diagnostic challenges. Tubal metaplasia may be encountered simultaneously with AIS or EAC, and cases of ciliated AIS and EAC have been reported [42, 43]. As such, recognizing cilia in a Pap smear does not rule out the possibility of a malignancy. In tandem with reactive/reparative endocervical cell atypia, fine chromatin pattern together with the lack of some typically AIS- and EAC-associated architectural features appear to be the most helpful cytomorphological features in the differential diagnosis of tubal metaplasia and endocervical malignancies.

In our study, a fifth of the benign biopsies presented with microglandular hyperplasia, which in turn was associated with nuclear elongation in cytology. Investigations of larger series are required to reveal the significance of this finding since nuclear elongation is an important feature of AEC, FN, and AIS, as defined by TBSRCC 2014, and has not been described in association with microglandular hyperplasia in previous studies (Table 4). Instead, cytological features of microglandular hyperplasia that might lead to diagnosis of AEC, NOS reportedly include three-dimensional cell groups, usually with preserved cell polarity, small gland-like spaces and a variation of cell size from small to large. The nuclei in microglandular hyperplasia can be either cubic, cylindrical, or rounded, occasionally hyperchromatic, and their chromatin pattern can be coarsely granular (Table 4). In histology, atypical and mitotically active forms of microglandular hyperplasia have been described, and cells from these lesions may be expected to cause diagnostic problems in cytology [44, 45].

In our study, the overall scant cellularity in Pap smears was correlated with granulation tissue formation in histology, which could be expected in the absence of surface epithelium. In addition, palisading cell borders showed a correlation with granulation tissue. No other reports of the cytological features of granulation tissue were found in the literature.

In line with several previous studies, all our benign follow-up biopsies harboured some histological changes [2, 5, 11, 28]. However, others reported no histological abnormalities, potentially explaining the cytological glandular atypia in 10–71% of the cases [3, 7, 8, 12, 30, 46].

HPV infections are known to have a high spontaneous clearance rate, and most of the histological LSIL, and even some CIN2 lesions, spontaneously regress [47‒50]. In a Brazilian cross-sectional study, 41% of HPV-positive cases with glandular cytological abnormalities had normal Pap smear and colposcopy in a follow-up [51]. Furthermore, the time-honoured concept does not appear to work for glandular abnormalities in the same pattern as that for squamous cell precursor lesions [52]. Although the pathogenesis and natural history of the endocervical glandular malignancies is less well established than that of the squamous lesions, we may nonetheless speculate as to whether HPV infection also induces similar, later regressing changes on the glandular epithelium. This would explain why some of the follow-up histology samples showed no changes that could explain the cytological glandular atypia. Of course, the phenomenon may also be a matter of sampling error or diagnostic error, given that mild cytological atypia is known to be problematic with poor reproducibility [53‒57].

Degeneration and nuclear crowding were identified as the strongest features separating the benign-proven AEC, NOS Pap smears from those harbouring a malignancy since both were more common in cases histologically verified as malignant. In previous studies, degeneration has also been described as one of the features that obscures the neoplastic nature of the atypical cells seen in Pap smears [1, 53]. Likewise, in agreement with our findings, crowded fragments have previously been reported among a combination of cytomorphological features in cases correctly diagnosed as endocervical glandular neoplasia [1, 15, 53].

Owing to our strict inclusion criteria, the present study’s sample size remained relatively small, which is an obvious limiting factor and a possible explanation as to why the investigated cytomorphological features did not show more specific association with any of the histological findings. In addition, we only had conventional smears available for analysis. However, this was a blinded study rather than a retrospective morphological analysis only. Moreover, our benign cases had a relatively long follow-up period, and HPV status history was available, both of which support the interpretation that cellular changes observed in their Pap smears truly were non-neoplastic in origin.

In summary, it is evident that additional tools, besides cytomorphology, are required to reliably distinguish between mild glandular atypia related to benign changes from those harbouring a malignancy. In our study, all the benign-proven AEC, NOS cases were either hrHPV-negative at the study baseline or turned negative during the study period. Most of the AIS and EAC are known to be hrHPV-associated [58‒60]. Thus, hrHPV negativity appears to be the best indicator of benign endocervical glandular cell atypia. Meanwhile, hrHPV-positive cases are problematic and will continue to be a source of overdiagnoses and added costly diagnostic procedures until more specific biomarkers are introduced. Among liquid-based cervical cytological samples with mild squamous atypia, the use of p16/Ki-67 dual stain has been shown to be more specific than the hrHPV testing and cytology in detecting HSILs and carcinomas [61, 62]. Although the data are still limited, the p16/Ki-67 dual stain also appears to be useful in the diagnosis of endocervical glandular atypia [62].

The study protocol was reviewed and approved by the Ethical Committee of Pirkanmaa Health Care District with approval number R16022. The study was based on archive samples and therefore had no impact on the treatment or the follow-up of the patients. The study was conducted without informed consent of each individual, which was approved by the Ethical Committee of Pirkanmaa Health Care District. The study was conducted according to the Declaration of Helsinki.

The authors have no conflicts of interest to declare.

The work was supported by grants from the VTR Funding, Ida Montin Foundation, and Emil Aaltonen Foundation. The funding sources had no role in the preparation of data or the manuscript.

Johanna Pulkkinen: data curation, formal analysis, investigation, project administration, visualization, validation, writing – original draft, and editing. Heini Huhtala: data curation, statistical analyses, supervision, and writing – original draft. Ivana Kholová: conceptualization, data curation, formal analysis, investigation, methodology, project administration, resources, visualization, supervision, validation, writing – original draft, and editing.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

1.
Lee
KR
,
Manna
EA
,
St John
T
.
Atypical endocervical glandular cells: accuracy of cytologic diagnosis
.
Diagn Cytopathol
.
1995
;
13
(
3
):
202
8
.
2.
Chen
L
,
Yang
B
.
Assessment of reflex human papillomavirus DNA testing in patients with atypical endocervical cells on cervical cytology
.
Cancer Cytopathology
.
2008
;
114
(
4
):
236
41
.
3.
Nasu
I
,
Meurer
W
,
Fu
YS
.
Endocervical glandular atypia and adenocarcinoma: a correlation of cytology and histology
.
Int J Gynecol Pathol
.
1993
;
12
(
3
):
208
18
.
4.
Pulkkinen
J
,
Kares
S
,
Huhtala
H
,
Kholová
I
.
Detection and outcome of endocervical atypia in cytology in primary HPV screening programme
.
Diagnostics
.
2021
;
11
(
12
):
2402
.
5.
Selvaggi
SM
.
Glandular epithelial abnormalities on Thinprep® pap tests: clinical and cytohistologic correlation
.
Diagn Cytopathol
.
2016
;
44
(
5
):
389
93
.
6.
Lai
CR
,
Hsu
CY
,
Tsay
SH
,
Li
A
.
Clinical significance of atypical glandular cells by the 2001 Bethesda system in cytohistologic correlation
.
Acta Cytol
.
2008
;
52
(
5
):
563
7
.
7.
Burja
IT
,
Thompson
SK
,
Sawyer
WL
Jr
,
Shurbaji
MS
.
Atypical glandular cells of undetermined significance on cervical smears. A study with cytohistologic correlation
.
Acta Cytol
.
1999
;
43
(
3
):
351
6
.
8.
Kim
MK
,
Lee
YK
,
Hong
SR
,
Lim
KT
.
Clinicopathological significance of atypical glandular cells on cervicovaginal Pap smears
.
Diagn Cytopathol
.
2017
;
45
(
10
):
867
72
.
9.
Pradhan
D
,
Li
Z
,
Ocque
R
,
Patadji
S
,
Zhao
C
.
Clinical significance of atypical glandular cells in pap tests: an analysis of more than 3,000 cases at a large academic women’s center
.
Cancer Cytopathol
.
2016
;
124
(
8
):
589
95
.
10.
Zhao
C
,
Florea
A
,
Onisko
A
,
Austin
RM
.
Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods
.
Gynecol Oncol
.
2009
;
114
(
3
):
383
9
.
11.
Ajit
D
,
Gavas
S
,
Joseph
S
,
Rekhi
B
,
Deodhar
K
,
Kane
S
.
Identification of atypical glandular cells in pap smears: is it a hit and miss scenario
.
Acta Cytol
.
2013
;
57
(
1
):
45
53
.
12.
Schnatz
PF
,
Guile
M
,
O’Sullivan
DM
,
Sorosky
JI
.
Clinical significance of atypical glandular cells on cervical cytology
.
Obstet Gynecol
.
2006 Mar
107
3
701
8
. https://doi.org/10.1097/01.AOG.0000202401.29145.68.
13.
Westin
M
,
Derchain
SF
,
Rabelo-Santos
SH
,
Angelo-Andrade
LA
,
Sarian
LO
,
Oliveira
E
et al
.
Atypical glandular cells and adenocarcinoma in situ according to the Bethesda 2001 classification: cytohistological correlation and clinical implications
.
Eur J Obstet Gynecol Reprod Biol
.
2008
;
139
(
1
):
79
85
.
14.
Rabelo Santos
SH
,
Derchain
SFM
,
Do Amaral Westin
MC
,
Angelo-Andrade
LAL
,
Sarian
LOZ
,
Oliveira
ERZM
et al
.
Endocervical glandular cell abnormalities in conventional cervical smears: evaluation of the performance of cytomorphological criteria and HPV testing in predicting neoplasia
.
Cytopathology
.
2008
;
19
(
1
):
34
43
.
15.
Mariani
R
,
Grace
C
,
Hughes
K
,
Dietrich
RM
,
Cabay
RJ
,
David
O
.
Can we improve the positive predictive value of atypical glandular cells not otherwise specified
.
Diagn Cytopathol
.
2014
;
42
(
3
):
200
4
.
16.
Conrad
RD
,
Liu
AH
,
Wentzensen
N
,
Zhang
RR
,
Dunn
ST
,
Wang
SS
et al
.
Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis
.
Cancer Cytopathol
.
2018
;
126
(
11
):
950
8
.
17.
Pulkkinen
J
,
Huhtala
H
,
Kholová
I
.
The role of pap smear in the diagnostics of endocervical adenocarcinoma
.
APMIS
.
2021
;
129
(
4
):
195
203
.
18.
Colgan
TJ
,
Woodhouse
SL
,
Styer
PE
,
Kennedy
M
,
Davey
DD
.
Reparative changes and the false-positive/false-negative papanicolaou test: a study from the college of American pathologists interlaboratory comparison program in cervicovaginal cytology
.
Arch Pathol Lab Med
.
2001 Jan
125
1
134
40
.
19.
Yahr
LJ
,
Lee
KR
.
Cytologic findings in microglandular hyperplasia of the cervix
.
Diagn Cytopathol
.
1991
;
7
(
3
):
248
51
.
20.
Selvaggi
SM
,
Haefner
HK
.
Microglandular endocervical hyperplasia and tubal metaplasia: pitfalls in the diagnosis of adenocarcinoma on cervical smears
.
Diagn Cytopathol
.
1997 Feb
16
2
168
73
. https://doi.org/10.1002/(sici)1097-0339(199702)16:2<168::aid-dc15>3.0.co;2-k.
21.
Alvarez-Santín
C
,
Sica
A
,
Rodríguez
M
,
Feijó
A
,
Garrido
G
.
Microglandular hyperplasia of the uterine cervix. Cytologic diagnosis in cervical smears
.
Acta Cytol
.
1999
;
43
(
2
):
110
3
.
22.
Wilbur
DC
.
Practical issues related to uterine pathology: in situ and invasive cervical glandular lesions and their benign mimics: emphasis on cytology–histology correlation and interpretive pitfalls
.
Mod Pathol
.
2016 Jan
29
Suppl 1
S1
11
.
23.
Wilbur
DC
,
Chhieng
DC
,
Guidos
B
,
Mody
DR
.
Epithelial abnormalities: glandular
3rd ed. In:
Nayar
R
,
Wilbur
DC
, editors.
Bethesda system for reporting cervical cytology
.
Springer
.
2015
. p.
193
240
.
24.
Abdul-Karim
FW
,
Powers
CN
,
Bererk
JS
,
Sherman
ME
,
Tabbara
SO
,
Sidawy
MK
.
Atypical squamous cells
3rd ed. In:
Nayar
R
,
Wilbur
DC
, editors.
Bethesda system for reporting cervical cytology
.
Springer
.
2015
. p.
103
34
.
25.
Henry
MR
,
Russel
DK
,
Luff
RD
,
Prey
MU
,
Wright
TC
Jr
,
Nayar
R
.
Epithelial abnormalities: squamous
3rd ed. In:
Nayar
R
,
Wilbur
DC
, editors.
Bethesda system for reporting cervical cytology
.
Springer
.
2015
. p.
135
92
.
26.
Kares
S
,
Veijalainen
O
,
Kholová
I
,
Tirkkonen
M
,
Vuento
R
,
Huhtala
H
et al
.
HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping
.
APMIS
.
2019 Nov
127
11
710
6
.
27.
Koss
LG
,
Melamed
MR
Koss’ diagnostic cytology and its histopathologic bases
Philadelphia
Lippincot Williams & Wilkins
.
2006
. p.
183
490
.
28.
Kawano
K
,
Yamaguchi
T
,
Nasu
H
,
Nishio
S
,
Ushijima
K
.
Subcategorization of atypical glandular cells is useful to identify lesion site
.
Diagn Cytopathol
.
2020
;
48
(
12
):
1224
9
.
29.
Yucel Polat
A
,
Tepeoglu
M
,
Tunca
MZ
,
Ayva
ES
,
Ozen
O
.
Atypical glandular cells in Papanicolaou test: which is more important in the detection of malignancy, architectural or nuclear features
.
Cytopathology
.
2021
;
32
(
3
):
344
52
.
30.
Schindler
S
,
Pooley
RJ
Jr
,
De Frias
DV
,
Yu
GH
,
Bedrossian
CW
.
Follow-up of atypical glandular cells in cervical-endocervical smears
.
Ann Diagn Pathol
.
1998
;
2
(
5
):
312
7
.
31.
Ghorab
Z
,
Mahmood
S
,
Schinella
R
.
Endocervical reactive atypia: a histologic-cytologic study
.
Diagn Cytopathol
.
2000
;
22
(
6
):
342
6
.
32.
Ronnett
BM
,
Manos
MM
,
Ransley
JE
,
Fetterman
BJ
,
Kinney
WK
,
Hurley
LB
et al
.
Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection
.
Hum Pathol
.
1999
;
30
(
7
):
816
25
.
33.
Levine
PH
,
Elgert
P
,
Sun
P
,
Simsir
A
.
Atypical repair on Pap smears: clinicopathologic correlates in 647 cases
.
Diagn Cytopathol
.
2005
;
33
(
3
):
214
7
.
34.
Ng
WK
,
Li
ASM
,
Cheung
LKN
.
Significance of atypical repair in liquid-based gynecologic cytology: a follow-up study with molecular analysis for human papillomavirus
.
Cancer
.
2003
;
99
(
3
):
141
8
.
35.
Rimm
DL
,
Gmitro
S
,
Frable
W
.
Atypical reparative change on cervical/vaginal smears may be associated with dysplasia
.
Diagn Cytopathol
.
1996
;
14
(
4
):
374
9
. https://doi.org/10.1002/(SICI)1097-0339(199605)14:4<374::AID-DC17>3.0.CO;2-H.
36.
Wood
MD
,
Horst
JA
,
Bibbo
M
.
Weeding atypical glandular cell look-alikes from the true atypical lesions in liquid-based Pap tests: a review
.
Cytopathology
.
2007
;
35
(
1
):
12
7
.
37.
Ozkan
F
,
Ramzy
I
,
Mody
DR
.
Glandular lesions of the cervix on thin-layer Pap tests. Validity of cytologic criteria used in identifying significant lesions
.
Acta Cytol
.
2004
;
48
(
3
):
372
9
.
38.
DiTomasso
JP
,
Ramzy
I
,
Mody
DR
.
Glandular lesions of the cervix. Validity of cytologic criteria used to differentiate reactive changes, glandular intraepithelial lesions and adenocarcinoma
.
Acta Cytol
.
1996
;
40
(
6
):
1127
35
.
39.
Torous
VF
,
Pitman
MB
.
Interpretation pitfalls and malignant mimics in cervical cytology
.
J Am Soc Cytopathol
.
2021
;
10
(
2
):
115
27
.
40.
Babkowski
RC
,
Wilbur
DC
,
Rutkowski
MA
,
Facik
MS
,
Bonfiglio
TA
.
The effects of endocervical canal topography, tubal metaplasia, and high canal sampling on the cytologic presentation of nonneoplastic endocervical cells
.
Am J Clin Pathol
.
1996
;
105
(
4
):
403
10
.
41.
Ducatman
BS
,
Wang
HH
,
Jonasson
JG
,
Hogan
CL
,
Antonioli
DA
.
Tubal metaplasia: a cytologic study with comparison to other neoplastic and non-neoplastic conditions of the endocervix
.
Diagn Cytopathol
.
1993
;
9
(
1
):
98
103
; discussion 103-5.
42.
Marketkar
S
,
Ou
J
,
James Sung
C
,
Ruhul Quddus
M
.
Ciliated/tubal-type in-situ and invasive endocervical adenocarcinoma: report of 3 cases with limited follow-up and review of the literature
.
Gynecol Oncol Rep
.
2022
;
42
:
101025
.
43.
Crum
CP
,
Hoang
LN
,
Kong
CS
,
Park
KJ
,
Parra-Herran
C
.
Adenocarcinoma in situ, HPV-associated of the uterine cervix
5th ed
WHO classification of tumors editorial board. Female genital tumors
Lyon (France)
International Agency for Research on Cancer
.
2020
. p.
364
6
.
44.
Abi-Raad
R
,
Alomari
A
,
Hui
P
,
Buza
N
.
Mitotically active microglandular hyperplasia of the cervix: a case series with implications for the differential diagnosis
.
Int J Gynecol Pathol
.
2014
;
33
(
5
):
524
30
.
45.
Young
RH
,
Scully
RE
.
Atypical forms of microglandular hyperplasia of the cervix simulating carcinoma. A report of five cases and review of the literature
.
Am J Surg Pathol
.
1989
;
13
(
1
):
50
6
.
46.
Hare
AA
,
Duncan
AR
,
Sharp
AJ
.
Cytology suggestive of glandular neoplasia: outcomes and suggested management
.
Cytopathol
.
2003
;
14
(
1
):
12
8
.
47.
Moscicki
AB
,
Shiboski
S
,
Broering
J
,
Powell
K
,
Clayton
L
,
Jay
N
et al
.
The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women
.
J Pediatr
.
1998
;
132
(
2
):
277
84
.
48.
Moscicki
AB
,
Shiboski
S
,
Hills
NK
,
Powell
KJ
,
Jay
N
,
Hanson
EN
et al
.
Regression of low-grade squamous intra-epithelial lesions in young women
.
Lancet
.
2004
;
364
(
9446
):
1678
83
.
49.
Petry
KU
,
Horn
J
,
Luyten
A
,
Mikolajczyk
RT
.
Punch biopsies shorten time to clearance of high-risk human papillomavirus infections of the uterine cervix
.
BMC Cancer
.
2018
;
18
(
1
):
318
.
50.
Loopik
DL
,
Bentley
HA
,
Eijgenraam
MN
,
IntHout
J
,
Bekkers
RLM
,
Bentley
JR
.
The natural history of cervical intraepithelial neoplasia grades 1, 2, and 3: a systematic review and meta-analysis
.
J Low Genit Trac Dis
.
2021
;
25
(
3
):
221
31
.
51.
Derchain
SFM
,
Rabelo-Santos
SH
,
Sarian
LO
,
Zeferino
LC
,
de Oliveira Zambeli
ER
,
do Amaral Westin
MC
et al
.
Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears
.
Gynecol Oncol
.
2004 Dec
95
3
618
23
.
52.
Syrjänen
K
.
Is improved detection of adenocarcinoma in situ by screening a key to reducing the incidence of cervical adenocarcinoma
.
Acta Cytol
.
2004 Sep–Oct
48
5
591
4
.
53.
Pulkkinen
J
,
Huhtala
H
,
Krogerus
LA
,
Hollmén
S
,
Laurila
M
,
Kholová
I
.
Endocervical cytology: inter- and intra-observer variability in conventional pap smears
.
Acta Cytol
.
2022
;
66
(
3
):
206
15
.
54.
Simsir
A
,
Hwang
S
,
Cangiarella
J
,
Elgert
P
,
Levine
P
,
Sheffield
MV
et al
.
Glandular cell atypia on papanicolaou smears: interobserver variability in the diagnosis and prediction of cell of origin
.
Cancer
.
2003
;
99
(
6
):
323
30
.
55.
Confortini
M
,
Di Bonito
L
,
Carozzi
F
,
Ghiringhello
B
,
Montanari
G
,
Parisio
F
et al
.
Interlaboratory reproducibility of atypical glandular cells of undetermined significance: a national survey
.
Cytopathol
.
2006
;
17
(
6
):
353
60
.
56.
Lee
KR
,
Darragh
TM
,
Joste
NE
,
Krane
JF
,
Sherman
ME
,
Hurley
LB
et al
.
Atypical glandular cells of undetermined significance (AGUS): interobserver reproducibility in cervical smears and corresponding thin-layer preparations
.
Am J Clin Pathol
.
2002
;
117
(
1
):
96
102
.
57.
Lepe
M
,
Eklund
CM
,
Quddus
MR
,
Paquette
C
.
Atypical glandular cells: interobserver variability according to clinical management
.
Acta Cytol
.
2018
62
5–6
397
404
.
58.
Molijn
A
,
Jenkins
D
,
Chen
W
,
Zhang
X
,
Pirog
E
,
Enqi
W
et al
.
The complex relationship between human papillomavirus and cervical adenocarcinoma
.
Int J Cancer
.
2016
;
138
(
2
):
409
16
.
59.
Pirog
EC
,
Lloveras
B
,
Molijn
A
,
Tous
S
,
Guimerà
N
,
Alejo
M
et al
.
HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases
.
Mod Pathol
.
2014
;
27
(
12
):
1559
67
.
60.
de Sanjose
S
,
Quint
WG
,
Alemany
L
,
Geraets
DT
,
Klaustermeier
JE
,
Lloveras
B
et al
.
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
.
Lancet Oncol
.
2010
;
11
:
1048
56
.
61.
Voidăzan
ST
,
Dianzani
C
,
Husariu
MA
,
Geréd
B
,
Turdean
SG
,
Uzun
CC
et al
.
The role of p16/ki-67 immunostaining, hTERC amplification and fibronectin in predicting cervical cancer progression: a systematic review
.
Biology
.
2022
;
11
(
7
):
956
.
62.
Yu
L
,
Fei
L
,
Liu
X
,
Pi
X
,
Wang
L
,
Chen
S
.
Application of p16/Ki-67 dual-staining cytology in cervical cancers
.
J Cancer
.
2019
;
10
(
12
):
2654
60
.